Neoadjuvant combination for stage II-III breast cancer

被引：0
|
作者：
Bagchi, Sanjit
机构：
来源：
LANCET ONCOLOGY | 2007年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(07)70195-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：579 / 579
页数：1
相关论文
共 50 条
  • [1] A randomized phase II neoadjuvant trial in patients with stage II-III and inflammatory breast cancer
    Somlo, G.
    Paz, B.
    Shen, J.
    Garberoglio, C.
    Luu, T.
    Chung, C.
    Hurria, A.
    Frankel, P.
    Baker, N.
    Wilczynski, S.
    Arnold, K.
    Yeb, Y.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S231 - S231
  • [2] Metformin with neoadjuvant chemotherapy in stage II-III breast cancer: A phase II clinical trial
    Azazy, H. A.
    Gado, N. M.
    Salem, D. A.
    El-Ghamry, W. R.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S323 - S324
  • [3] Role of Postmastectomy Radiation After Neoadjuvant Chemotherapy in Stage II-III Breast Cancer
    Fowble, Barbara L.
    Einck, John P.
    Kim, Danny N.
    McCloskey, Susan
    Mayadev, Jyoti
    Yashar, Catheryn
    Chen, Steven L.
    Hwang, E. Shelley
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 494 - 503
  • [4] Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience
    Zaher, Haidi Abd El
    Fathy, Hamada
    Abozeid, Mohamed
    Faisal, Mohammed
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [5] Neoadjuvant Treatment Approaches for Stage II-III Rectal Cancer
    Nurkin, Steven
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 572 - 575
  • [6] Neoadjuvant biweekly chemotherapy with liposomal doxorubicin and docetaxel in patients with stage II-III breast cancer
    Alvarez, I
    Modolell, A.
    Mayordomo, J., I
    Heras, L.
    Villadiego, K.
    Rolfo, C. D.
    Garcia-Bueno, J. M.
    Pica, P.
    Murillo, L.
    Morales, S.
    Valera, P.
    Florian, J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [7] Predictors of Recurrences in Stage II-III Breast Cancer in Patients Receiving Neoadjuvant Systemic Therapy
    Dayyat, A.
    Mheid, S.
    Erjan, A.
    AlHammadi, A.
    Alnsoor, A.
    Abdelrahman, F.
    Al Masri, H.
    Al-Rashdan, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E2 - E2
  • [8] Pegylated liposomal doxorubicin as neoadjuvant therapy for stage II-III locally advanced breast cancer
    Yao, Jia
    Pan, Shaobo
    Fan, Xiao
    Jiang, Xue
    Yang, Yuhong
    Jin, Jing
    Liu, Yu
    [J]. JOURNAL OF CHEMOTHERAPY, 2020, 32 (04) : 202 - 207
  • [9] Paclitaxel and cisplatin as neoadjuvant chemotherapy in bladder cancer (stage II-III).
    Quintero-Aldana, G
    Vázquez-Estevez, S
    Sabin-Dominguez, P
    Mel-Lorenzo, JR
    Bermudez-Cancelo, JM
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S50 - S50
  • [10] Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer
    Carillio, G.
    Aiello, R.
    Ali, M.
    Mazzola, A.
    Scandurra, G.
    Taibi, E.
    Chiarenza, M.
    Fallica, G.
    Caruso, F.
    Caruso, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345